CN109498714A - 当归芍药散 - Google Patents
当归芍药散 Download PDFInfo
- Publication number
- CN109498714A CN109498714A CN201811559090.2A CN201811559090A CN109498714A CN 109498714 A CN109498714 A CN 109498714A CN 201811559090 A CN201811559090 A CN 201811559090A CN 109498714 A CN109498714 A CN 109498714A
- Authority
- CN
- China
- Prior art keywords
- parts
- danggui shaoyao
- shaoyao san
- rhizoma
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000009362 danggui-shaoyao-san Substances 0.000 title claims abstract description 32
- 241000736199 Paeonia Species 0.000 claims abstract description 16
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 15
- 206010065390 Inflammatory pain Diseases 0.000 claims abstract description 14
- 239000007924 injection Substances 0.000 claims abstract description 12
- 238000002347 injection Methods 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 244000197580 Poria cocos Species 0.000 claims abstract description 9
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 9
- 210000000056 organ Anatomy 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 5
- 230000003902 lesion Effects 0.000 claims abstract description 5
- 239000006072 paste Substances 0.000 claims abstract description 5
- 239000006187 pill Substances 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims abstract description 5
- 239000003826 tablet Substances 0.000 claims abstract description 5
- 238000009472 formulation Methods 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 2
- 235000014347 soups Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- -1 decoction Substances 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 40
- 208000002193 Pain Diseases 0.000 description 36
- 230000036407 pain Effects 0.000 description 35
- 206010016059 Facial pain Diseases 0.000 description 14
- 206010061218 Inflammation Diseases 0.000 description 14
- 230000004054 inflammatory process Effects 0.000 description 14
- 206010013935 Dysmenorrhoea Diseases 0.000 description 13
- 208000004371 toothache Diseases 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 241000700159 Rattus Species 0.000 description 12
- 208000005171 Dysmenorrhea Diseases 0.000 description 11
- 238000003304 gavage Methods 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000004291 uterus Anatomy 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 208000009019 Pericoronitis Diseases 0.000 description 3
- 201000004328 Pulpitis Diseases 0.000 description 3
- 206010037464 Pulpitis dental Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 244000236658 Paeonia lactiflora Species 0.000 description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000001847 jaw Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 229920000638 styrene acrylonitrile Polymers 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 206010027951 Mood swings Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000134128 Syncope Species 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000001618 algogenic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000003074 dental pulp Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- BGOFCVIGEYGEOF-UJPOAAIJSA-N helicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1C=O BGOFCVIGEYGEOF-UJPOAAIJSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000008629 longdanxiegan Substances 0.000 description 1
- 210000004373 mandible Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000004357 third molar Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000008530 yinqiaosan Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种当归芍药散,包括以下重量份的药材:当归0‑15份:芍药4‑19份:茯苓4份:白术4份:泽泻8份:川芎8份。本发明的当归芍药散的有益效果是从汤剂作用效果获得的,适合于汤剂、丸剂、散剂、膏剂、丹剂、酒剂、冲剂、口服液剂、胶囊剂、片剂、注射剂等常用剂型,可以有效的治疗和缓解口腔颌面部的各类炎症性痛症,同时也可以治疗和缓解身体各器官病变引起的各类炎性痛症。
Description
技术领域
本发明涉及医药技术领域,尤其涉及一种当归芍药散。
背景技术
1、口腔颌面部炎症性疼痛
口腔颌面部疼痛为口腔、颌面、颈部组织器官等(如牙齿)各种性质疼痛的总称,表现为急性疼痛和慢性疼痛两类。根据口腔颌面部解剖结构的复杂性、疾病的病因、临床特点,将口颌面部疼痛分为炎性疼痛、创伤性疼痛、肿瘤性疼痛、关节疼痛、神经性疼痛、医源性疼痛和心理因素性疼痛等。
口腔颌面部炎性疼痛,炎性疼痛是由各种生物(细菌、真菌、病毒等)、物理、化学或免疫源性炎症所致的疼痛。
在口腔颌面部,由炎症引起的疼痛主要有牙髓炎、根尖周炎、智齿冠周炎、间隙感染、腮腺炎、下颌下腺炎、关节炎等。牙痛是口腔临床上最常见的症状之一。急性牙髓炎、急性根尖周炎、冠周炎等常表现为尖锐自发痛。慢性牙龈***炎等常表现为自发钝痛。牙本质过敏、二度或三度龋齿、楔状缺损等常表现为激发痛。
炎症疼痛机制复杂,受多种因素调控,主要机制:1)、炎症局部分解代谢增强,炎症介质如***素、5-羟色胺、缓激肽等,肿瘤坏死因子-α(TNF-α)和致痛物质等,刺激神经末梢引起疼痛; 2)、炎症渗出引起组织肿胀,张力升高,压迫或牵拉神经末梢引起疼痛。3)、牙髓炎、根尖周炎所引起的疼痛是由局部或全部牙髓的炎症导致牙髓腔压力升高,组织压升高,其压迫作用可使C纤维神经末梢兴奋,冲动传至中枢导致疼痛。
2、牙痛中医观点
祖国医学认为,“齿为骨之余”,“肾主骨”,足阳明胃之经脉络于龈中,所以齿与肾、龈与胃关系最为密切。从整体观念出发,牙痛往往与外邪侵袭、炎症、肝肾功能失调与不重视自我保健有关。一般而言,急性牙痛、牙龈红肿者,多从胃治;而慢性牙痛、齿松、齿痛隐隐、红肿不甚者,宜从肾治。中医把牙疼主要分为以下三种:
1)、风火牙痛牙痛剧烈,呈阵发性发作,遇风发作或加重,遇冷痛减,受热加重,牙龈红肿,全身常出现恶寒、发热、口渴、脉数等症状,多见于急性牙髓炎与根尖周炎初期。治宜疏风清热、解毒消肿,方用银翘散加减。 胃火牙痛疼痛剧烈,牙龈与颜面部红肿,或牙龈溢脓、牙龈出血,有时张口困难,同时可见头痛、口渴、口臭、尿少、便秘、发热、舌苔黄腻等症状,多见于冠周炎、化脓性根尖周炎。治宜清胃泻火、凉血止痛,方用清胃散加减。素体阴虚者,可用玉女煎加地骨皮、玄参。
2)、虚火牙痛牙齿隐隐作痛,程度较轻,午后与夜间可能加重,牙龈多不红肿,常出现牙齿松动、咬物无力且疼痛加剧或牙龈出血。全身可伴有腰酸、头晕、口干咽燥、舌红苔白、脉细数等症状。多见于老人慢性牙周病。治宜滋阴益肾、降火止痛,方用知柏地黄汤加减。
3)、肝火牙痛牙痛牵引头痛,情绪波动时发作或加重,全身常伴有口苦、目赤、耳鸣、胁痛、烦躁易怒、舌红苔黄、脉数有力等症状。宜清泻肝胆、疏肝止痛,方用龙胆泻肝汤去木通,加黄连、丹皮治之。
3、痛经的中西医观点
痛经是年轻女性最常见的妇科疾病,是指行经前或行经期出现下腹坠、胀痛、伴有腰酸或其他不适,重症者伴有四肢发冷、寒战、恶心、呕吐、晕厥等症状,直接影响工作、生活与学习。痛经按照生殖器官有无器质性病变分为两类: 即原发性痛经和继发性痛经。原发性痛经也称之为功能性痛经,多数患者自***后即有症状,主要表现为行经第一日疼痛厉害,持续2~3d后好转,经后症状消失。
血清***素含量增高,引起子宫壁螺旋动脉和子宫平滑肌强烈收缩、同时缺血缺氧提高外周神经对疼痛的敏感性引起痛经,这一理论被许多学者公认为是形成痛经的主要机制。血管加压素与痛经有着不可分割的联系,该激素通过作用于子宫上的相应的受体,使子宫收缩加剧及肌肉运动,导致子宫血量减少,引起疼痛,血管加压素可以增加子宫对缩宫药物的敏感度,这也会导致血流量减少,引起痛经。内皮素和一氧化氮比例失调也可能是导致痛经的又一个重要原因。
中医病机中医认为,痛经的病根在子宫,“不通则痛”以及“不荣则痛”为主要病机,虚者主要表现为气血衰弱,肾亏等原因,导致子宫不能接受到本需要的物,称之“不荣则痛”;实者则是体内不缺少营养物质,而是由于运输的通道不通,也就是常说的气滞血瘀、湿热瘀阻或寒凝血瘀,导致子宫的血气运行不畅通,称之“不通则痛”。中医中药疗法中医中药用于治疗原发性痛经,效果已得到临床医生及患者肯定。
4、当归芍药散对痛症的作用
当归芍药散出自东汉张仲景的《金匮要略》(妇人怀娠,腹中痛,当归芍药散主之。当归芍药散方:当归三两,芍药一斤,茯苓四两,白术四两,泽泻半斤,川芎半斤。上六味,杵为散,取方寸匕,酒和,日三服)。该药原为妇科名方,功能养血调肝,健脾利湿,主要用来治疗妊娠腹痛。后世医家在此基础上或有增减,或调其用量,但其功能仍主要为:养血、活血、止痛、利湿、调肝、柔肝,用于治疗***功能紊乱、卵巢功能不全、先兆流产、慢性肾炎、高血压病、更年期综合症、***等疾病。
然而,对于当归芍药散用于缓解口腔颌面部各类疼痛的研究并不多见,因此,提出当归芍药散。
发明内容
基于背景技术存在的技术问题,本发明提出了当归芍药散。
本发明提出的当归芍药散,包括以下重量份的药材:当归0-15份:芍药4-19份:茯苓4份:白术4份:泽泻8份:川芎8份。
优选的,包括以下重量份的药材:当归0份:芍药19份:茯苓4份:白术4份:泽泻8份:川芎8份。
当归芍药散的制备方法,包括以下步骤:
S1:根据国药标准选取高品质的当归、芍药、茯苓、白术、泽泻和川芎;
S2:将S1中所述的当归、芍药、茯苓、白术、泽泻和川芎按比例进行混合,得到混合物A;
S3:将S2中所述的混合物A放入蒸煮锅中,加入一定体积的蒸馏水进行浸泡和煎煮,然后进行固液分离得到第一药渣B和第一药水C;
S4:将S3中所述的第一药渣B放入蒸煮锅中,加入一定体积的蒸馏水进行煎煮,然后进行固液分离得到第二药渣D和第二药水E;
S5:将S4中所述的第二药水E和S3中所述的第一药水C进行混合后浓缩成1g生药/ml,就完成了当归芍药散的成品,并将当归芍药散成品放入4℃冰箱内进行备用,用时加热至温热。
优选的,所述S3中,加入蒸馏水的体积与混合物A的体积比为8:1。
优选的,所述S3中,浸泡时间为1h,且煎煮时间为2h。
优选的,所述S4中,加入蒸馏水的体积与第一药渣B的体积比为6:1。
优选的,所述S4中,煎煮时间为1.5h。
优选的,制备成各类剂型用于治疗和缓解口腔颌面部的各类炎症性痛症及身体各器官病变引起的各类炎性痛症,这些剂型包括汤剂、丸剂、散剂、膏剂、丹剂、酒剂、冲剂、口服液剂、胶囊剂、片剂、注射剂等常用剂型。
本发明的有益效果:本发明的当归芍药散的有益效果是从汤剂作用效果获得的,适合于汤剂、丸剂、散剂、膏剂、丹剂、酒剂、冲剂、口服液剂、胶囊剂、片剂、注射剂等常用剂型,可以有效的治疗和缓解口腔颌面部的各类炎症性痛症,同时也可以治疗和缓解身体各器官病变引起的各类炎性痛症。
附图说明
图1为颌面***疼痛模型大鼠上唇***扩散区示意图;
图2为当归芍药散处方的成为比例示意图;
图3为各时间段大鼠的挠脸行为总表;
图4为大鼠挠脸次数折线;
图5为不同药物对大鼠的同时间段挠脸次数的变化图;
图6为不同药物对大鼠的挠脸总数图。
具体实施方式
下面结合具体实施例对本发明作进一步解说。
1、按照当归和芍药的不同比例进行制作当归芍药散,具体当归芍药散处方的成为比例如图2所示。
2、当归芍药散汤剂的制备
当归芍药散一共包含中药均购自广东省药材公司,其成分和含量见上图。中药汤剂煎法如下:中药按比例混合后,加8倍体积的蒸馏水浸泡1h,然后煎2h,收集药水;再往药渣中加6倍体积蒸馏水,煎1.5h,收集药水;将两次收集的药水混合后浓缩成1g生药/ml,放4℃冰箱备用,用时加热至温热。
3、实验指标测定方法
(1)、林致颌面疼痛模型
所有动物适应性饲养1周。实验前两天,动物每天30min连续习惯实验设置,笼子为长×宽×高=47×25×21cm3的透明有机玻璃箱,在同一时间间隔(上午或下午8:00-11:00)和同样的光照和温度条件下完成实验。在实验当天,大鼠注射***前15分钟被安置在透明有机玻璃箱内。在所有实验中,同一助手用布手套轻柔地固定动物体部和头部,同一实验者用微量进样器快速进针,在大鼠右侧上唇皮下组织内注射2.5%***50µl,空白组注射等量的0.9%生理盐水。注射位置在右上唇触须垫边缘如图1所示,即上唇皮肤和粘膜交界处朝触须垫方向进针注射,使***溶液注入后分布于上唇和触须垫的前半部分。
(2)、行为学测定实验方法
所有***注射顺利大鼠均被即刻放入观察箱内进行行为记录和评估。以3min为单位,观察45分钟,分别记录不同组间大鼠用前/后爪抓擦右颌面部注射部位的次数作为动物疼痛的定量指标,全程记录。人工观察计时的同时,用高清数码HD摄像一体机记录动物疼痛行为全过程,便于以后统计分析。
4、分组和测定指标
(1)、分组
1)、正常对照组:正常鼠灌服等量生理盐水。
2)、痛模型组:***致颌面疼痛模型鼠+灌服等量生理盐水。
3)、性对照组:***致颌面疼痛模型鼠+阿司匹林0.1g/KG。
4)、0:19DSS组:***致颌面疼痛模型鼠+灌服0:32DSS 5ml,每天早上10时,连续3天。
5)、1:9DSS组:***致颌面疼痛模型鼠+灌服1:9DSS 5ml,每天早上10时,连续3天。
6)、1:7DSS组:***致颌面疼痛模型鼠+灌服1:7DSS 5ml,每天早上10时,连续3天。
7)、1:5DSS组:***致颌面疼痛模型鼠+灌服1:5DSS 5ml,每天早上10时,连续3天。
8)、1:3DSS组:***致颌面疼痛模型鼠+灌服1:3DSS 5ml,每天早上10时,连续3天。
9)、1:1DSS组:***致颌面疼痛模型鼠+灌服1:1DSS 5ml,每天早上10时,连续3天。
10)、3:1DSS组:***致颌面疼痛模型鼠+灌服3:1DSS 5ml,每天早上10时,连续3天。
11)、1:5.33DSS组:***致颌面疼痛模型鼠+灌服1:5.33DSS5ml,每天早上10时,连续3天。
12)、原方加味方组:***致颌面疼痛模型鼠+灌服原方加味方5ml,每天早上10时,连续3天。
(2)、测定指标
记录大鼠疼痛行为学指标。
1) 、以3min为单位大鼠用前/后爪抓擦右颌面部注射部位的次数, 共计观察45分钟,15个时间段的挠脸次数。
2)、大鼠1小时内的总挠脸次数。
5、当归芍药散处方比例缓解疼痛功效
(1)、不同药物处理***致颌面疼痛模型鼠的挠脸行为的影响如图3、图4和图5所示。
从挠脸行为总表及拆线图不同当归与芍药比例方药组均明显少于模型组,以无当归方药(0:19DSS组)减少最明显。
如图6所示,从挠脸总次数可看出,不同当归与芍药比例方药组均明显少于模型组,以无当归方药(0:19DSS组)减少最明。
(2)、结论
1)不同当归与芍药比例的当归芍药散处方均可缓解***致颌面疼痛功效。
2)当归与芍药比为0:19,即没有当归时,缓解***致颌面疼痛功效最佳。
本当归芍药散可制备成各类剂型用于治疗和缓解口腔颌面部的各类炎症性痛症及身体各器官病变引起的各类炎性痛症,这些剂型包括汤剂、丸剂、散剂、膏剂、丹剂、酒剂、冲剂、口服液剂、胶囊剂、片剂、注射剂等常用剂型。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (8)
1.当归芍药散,其特征在于,包括以下重量份的药材:当归0-15份:芍药4-19份:茯苓4份:白术4份:泽泻8份:川芎8份。
2.根据权利要求1所述的当归芍药散,其特征在于,包括以下重量份的药材:当归0份:芍药19份:茯苓4份:白术4份:泽泻8份:川芎8份。
3.根据权利要求1或2所述的当归芍药散的制备方法,其特征在于,包括以下步骤:
S1:根据国药标准选取高品质的当归、芍药、茯苓、白术、泽泻和川芎;
S2:将S1中所述的当归、芍药、茯苓、白术、泽泻和川芎按比例进行混合,得到混合物A;
S3:将S2中所述的混合物A放入蒸煮锅中,加入一定体积的蒸馏水进行浸泡和煎煮,然后进行固液分离得到第一药渣B和第一药水C;
S4:将S3中所述的第一药渣B放入蒸煮锅中,加入一定体积的蒸馏水进行煎煮,然后进行固液分离得到第二药渣D和第二药水E;
S5:将S4中所述的第二药水E和S3中所述的第一药水C进行混合后浓缩成1g生药/ml,就完成了当归芍药散的成品,并将当归芍药散成品放入4℃冰箱内进行备用,用时加热至温热。
4.根据权利要求2所述的当归芍药散的制备方法,其特征在于,所述S3中,加入蒸馏水的体积与混合物A的体积比为8:1。
5.根据权利要求2所述的当归芍药散的制备方法,其特征在于,所述S3中,浸泡时间为1h,且煎煮时间为2h。
6.根据权利要求2所述的当归芍药散的制备方法,其特征在于,所述S4中,加入蒸馏水的体积与第一药渣B的体积比为6:1。
7.根据权利要求2所述的当归芍药散的制备方法,其特征在于,所述S4中,煎煮时间为1.5h。
8.根据权利要求1或2所述的当归芍药散特征和配方,制备成各类剂型用于治疗和缓解口腔颌面部的各类炎症性痛症及身体各器官病变引起的各类炎性痛症,这些剂型包括汤剂、丸剂、散剂、膏剂、丹剂、酒剂、冲剂、口服液剂、胶囊剂、片剂、注射剂等常用剂型。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811559090.2A CN109498714B (zh) | 2018-12-19 | 2018-12-19 | 一种治疗炎性疼痛的当归芍药散及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811559090.2A CN109498714B (zh) | 2018-12-19 | 2018-12-19 | 一种治疗炎性疼痛的当归芍药散及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109498714A true CN109498714A (zh) | 2019-03-22 |
CN109498714B CN109498714B (zh) | 2021-06-08 |
Family
ID=65753817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811559090.2A Expired - Fee Related CN109498714B (zh) | 2018-12-19 | 2018-12-19 | 一种治疗炎性疼痛的当归芍药散及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109498714B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115779025A (zh) * | 2022-12-09 | 2023-03-14 | 贵州中医药大学第一附属医院 | 一种治疗女性痤疮的中药制剂及制备方法及制备方法 |
CN116920030A (zh) * | 2023-05-16 | 2023-10-24 | 海南医学院第二附属医院 | 一种治疗糖尿病周围神经病变气虚血瘀证的中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167901A (zh) * | 2006-10-26 | 2008-04-30 | 中国人民解放军军事医学科学院毒物药物研究所 | 当归芍药方提取物、其制备方法及医药用途 |
CN102846878A (zh) * | 2011-06-30 | 2013-01-02 | 苏州知微堂生物科技有限公司 | 一种当归芍药散整合型新剂型制备技术及其生产方法 |
-
2018
- 2018-12-19 CN CN201811559090.2A patent/CN109498714B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101167901A (zh) * | 2006-10-26 | 2008-04-30 | 中国人民解放军军事医学科学院毒物药物研究所 | 当归芍药方提取物、其制备方法及医药用途 |
CN102846878A (zh) * | 2011-06-30 | 2013-01-02 | 苏州知微堂生物科技有限公司 | 一种当归芍药散整合型新剂型制备技术及其生产方法 |
Non-Patent Citations (2)
Title |
---|
华永庆等: "当归芍药散治疗痛经的方药量效关系研究", 《中国临床药理学与治疗学》 * |
张冬雅等: "《妇产科疾病治疗与健康指导 上》", 30 June 2017, 吉林科学技术出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115779025A (zh) * | 2022-12-09 | 2023-03-14 | 贵州中医药大学第一附属医院 | 一种治疗女性痤疮的中药制剂及制备方法及制备方法 |
CN115779025B (zh) * | 2022-12-09 | 2024-02-23 | 贵州中医药大学第一附属医院 | 一种治疗女性痤疮的中药制剂及制备方法 |
CN116920030A (zh) * | 2023-05-16 | 2023-10-24 | 海南医学院第二附属医院 | 一种治疗糖尿病周围神经病变气虚血瘀证的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN109498714B (zh) | 2021-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102698121B (zh) | 用于治疗牙周炎的中药组合物、制备方法和牙膏 | |
CN102139030B (zh) | 一种治疗牙龈炎的口腔中药制剂及其制备方法 | |
CN102698122B (zh) | 用于治疗牙周炎的中药、制备方法、牙膏和给药方式 | |
CN109498714A (zh) | 当归芍药散 | |
CN102526342B (zh) | 一种治疗慢性***的中药制剂 | |
CN107334952B (zh) | 耳穴贴压、针刺联合中药治疗痰湿壅盛型原发性高血压及其应用 | |
CN102327450A (zh) | 一种治疗牙痛的药物 | |
CN101301366B (zh) | 一种治疗牙痛的中药组合物及其制备方法 | |
CN101411801A (zh) | 一种用于安胎的中药组合物及其制剂的制备方法 | |
CN102940716A (zh) | 一种治疗子宫脱垂的中药 | |
CN106620133A (zh) | 一种具有补肾壮阳、祛风湿功能的药酒及其制备方法 | |
CN105663408A (zh) | 一种治疗***及月经量过少的汤剂药物及制备方法 | |
CN105343675A (zh) | 一种治疗肥胖症的中药制剂及其制备方法 | |
CN103768439A (zh) | 一种调节内分泌的中药组合物及其制剂与制备方法 | |
CN104547396A (zh) | 一种治疗月经后期的中药组合物 | |
CN104208640A (zh) | 一种治疗月经延后的中药组合物 | |
CN115317564B (zh) | 一种治疗绝经前后诸证的中药组合物、制备方法及制剂 | |
CN104857094B (zh) | 一种中药组合物作为治疗口腔溃疡制剂的应用 | |
CN107007652A (zh) | 康复新液联合中药在制备治疗***症的药物中的用途 | |
CN103610992B (zh) | 一种治疗牙痛的中药口服液 | |
CN102743729B (zh) | 一种治疗妇科出血的口服止血汤及其制备方法 | |
CN103301373A (zh) | 一种治疗产后***粘膜病变的药物组合物 | |
CN103316270B (zh) | 一种治疗产后***粘膜病变药物的散剂制备方法 | |
CN116139236B (zh) | 一种治疗肝郁型失眠症的中药组合物及其应用 | |
CN102935118A (zh) | 一种治疗痔疮的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210608 Termination date: 20211219 |